Company Overview of Pacific GeneTech Limited
Pacific GeneTech Limited, a biotechnology company, engages in acquiring and developing technologies that addresses the threat of animal-origin viruses. It develops H5N1, an avian influenza vaccine for serotypes and poultry species, as well as conventional avian influenza vaccines for a specific serotype and species. The company has strategic partnerships with Asia Capital Management Limited, Phoenix, GT Alliances, and Tyson Foods. Pacific GeneTech Limited is based in Hong Kong, Hong Kong. It has subsidiaries in Hong Kong, Hong Kong, as well as in Arkansas.
17th Fl. China Hong Kong Tower
8-12 Hennessy Road
852 2525 8151
Key Executives for Pacific GeneTech Limited
Pacific GeneTech Limited Key Developments
Similar Private Companies By Industry
|Antiviral Technologies, Inc.||Asia|
|Bio-Cancer Treatment International Ltd.||Asia|
|Bio-Works Company Limited||Asia|
|China Gene, Ltd. (Hong Kong)||Asia|
|DiagCor Bioscience Incorporation Limited||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Pacific GeneTech Limited, please visit www.pacificgenetech.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.